Intuitive Surgical Earnings: 3 Things to Watch

Download Intuitive Surgical Earnings: 3 Things to Watch

Post on 16-Jul-2015



Economy & Finance

1 download

Embed Size (px)


PowerPoint Presentation

Intuitive Surgical Earnings:3 Things to WatchShort-Term Investors

Wall Street ExpectationsRevenue

Q2: $502 millionFull Year: $2.04 billion

Earnings per Share

Q2: $2.83Full Year: $11.58

Short-Term Investors

Because of uncertainty surrounding system sales in the United States, Intuitive Surgical hasnt been offering guidance.

That being said, how the company performs against expectations will go a long way in determining the stocks fate over the short-term.

It will be interesting to see if management feels comfortable reinstating guidance moving forward.Short-Term InvestorsMedium-Term Investors

daVinci System SalesMany investors will be watching to see if U.S. hospitals will start loosening the purse strings to buy more daVinci robots.Medium-Term Investors

For years, the company showed double digit growth in system sales for the daVinci in the United States. That growth actually went negative earlier this year.

Investors shouldnt read too much into the system sales themselves, as uncertainty surrounding the Affordable Care Act is still lingering, and hospitals are likely wanting to see if the new daVinci Xi is worth the money.

Instead, focus on management comments regarding reception to the Xi.Medium-Term InvestorsLong-Term Investors

More Surgical DiversityIn order to be continually relevant for decades to come, the daVinci needs to help doctors perform surgery in ever-more procedures.Long-Term Investors

Historically, the companys machine has been most oft-used to perform hysterectomies and prostatectomies.

Last year, however, leading voices in the womens health industry questioned the efficacy of using the daVinci to perform hysterectomies.

Some believe the new Xi will help diversify the types of procedures the daVinci can be used for. Listen in for specific results in general surgery, and comments by management.Long-Term Investors

Smart investors know dividend stocks like Abbott Labs crush their non-dividend paying counterparts over the long term. Our top analysts put together a report on a group of high-yielding stocks that should be in any income investors portfolio.


View more >